Study run-a1
Study informations
119 subnetworks in total page | file
406 genes associated page | file
Enriched GO terms page
General informations
General Index page
Study Index page
Subnetwork 6048-7-real
score
| Dataset | Score | P-val 1 | P-val 2 | P-val 3 |
|---|
| Desmedt | 0.1609 | 1.051e-02 | 1.256e-02 | 1.028e-01 |
|---|
| IPC-NIBC-129 | 0.2768 | 1.441e-02 | 1.663e-02 | 1.696e-01 |
|---|
| Ivshina_GPL96-GPL97 | 0.2459 | 5.710e-03 | 9.299e-03 | 1.858e-01 |
|---|
| Loi_GPL570 | 0.2691 | 4.255e-02 | 4.222e-02 | 2.260e-01 |
|---|
| Loi_GPL96-GPL97 | 0.1571 | 3.700e-05 | 2.060e-04 | 5.310e-04 |
|---|
| Parker_GPL1390 | 0.3474 | 1.682e-01 | 1.748e-01 | 6.821e-01 |
|---|
| Parker_GPL887 | 0.1116 | 6.081e-01 | 6.383e-01 | 6.569e-01 |
|---|
| Pawitan_GPL96-GPL97 | 0.3909 | 2.916e-01 | 2.521e-01 | 8.576e-01 |
|---|
| Schmidt | 0.2203 | 1.104e-02 | 1.571e-02 | 1.411e-01 |
|---|
| Sotiriou | 0.3091 | 3.083e-03 | 9.430e-04 | 7.246e-02 |
|---|
| Wang | 0.1793 | 1.160e-01 | 8.177e-02 | 4.021e-01 |
|---|
| Zhang | 0.1636 | 1.057e-01 | 7.002e-02 | 2.524e-01 |
|---|
| Zhou | 0.4002 | 4.562e-02 | 4.686e-02 | 2.915e-01 |
|---|
Expression data for subnetwork 6048-7-real in each dataset
Desmedt |
IPC-NIBC-129 |
Ivshina_GPL96-GPL97 |
Loi_GPL570 |
Loi_GPL96-GPL97 |
Parker_GPL1390 |
Parker_GPL887 |
Pawitan_GPL96-GPL97 |
Schmidt |
Sotiriou |
Wang |
Zhang |
Zhou |
Subnetwork structure for each dataset
- Desmedt
Score for each gene in subnetwork 6048-7-real in each dataset
| Gene Symbol | Links | Frequency | Frequency Rank | Subnetwork score rank | Global rank |
Desmedt | IPC-NIBC-129 | Ivshina_GPL96-GPL97 | Loi_GPL570 | Loi_GPL96-GPL97 | Parker_GPL1390 | Parker_GPL887 | Pawitan_GPL96-GPL97 | Schmidt | Sotiriou | Wang | Zhang | Zhou |
|---|
| ttk |   | 1 | 164 | 199 | 209 | 0.065 | 0.284 | 0.093 | 0.162 | 0.107 | 0.144 | 0.171 | 0.202 | 0.264 | 0.051 | 0.135 | 0.155 | 0.261 |
|---|
| cttn | | 9 | 27 | 44 | 37 | 0.067 | 0.065 | 0.123 | 0.238 | 0.126 | 0.263 | -0.172 | 0.216 | 0.069 | 0.115 | 0.129 | 0.025 | 0.279 |
|---|
| cdkn1a | | 70 | 3 | 73 | 51 | 0.115 | -0.020 | 0.065 | 0.082 | 0.099 | 0.124 | 0.055 | 0.087 | 0.068 | 0.144 | 0.015 | -0.201 | 0.069 |
|---|
| tubb | | 8 | 33 | 93 | 80 | 0.107 | 0.221 | 0.070 | 0.090 | 0.095 | 0.278 | -0.325 | 0.185 | 0.139 | 0.202 | -0.061 | -0.142 | 0.101 |
|---|
| ube2d2 | | 1 | 164 | 199 | 209 | 0.026 | 0.149 | 0.122 | 0.166 | 0.143 | 0.058 | -0.073 | 0.120 | 0.071 | 0.137 | 0.052 | 0.012 | 0.228 |
|---|
| fhod1 | | 3 | 79 | 88 | 86 | 0.050 | 0.216 | 0.126 | -0.110 | 0.073 | 0.134 | -0.082 | 0.094 | -0.080 | -0.013 | 0.046 | 0.075 | 0.207 |
|---|
| ccnb1 | | 36 | 7 | 78 | 59 | 0.082 | 0.246 | 0.212 | 0.224 | 0.256 | 0.099 | 0.126 | 0.351 | 0.129 | 0.249 | 0.152 | 0.167 | 0.398 |
|---|
| ccnd1 | | 102 | 2 | 1 | 2 | 0.127 | -0.183 | 0.062 | 0.190 | 0.157 | -0.002 | -0.190 | 0.105 | -0.107 | 0.174 | 0.106 | 0.144 | 0.290 |
|---|
| cdc2 | | 103 | 1 | 1 | 1 | 0.073 | 0.247 | 0.206 | 0.172 | 0.247 | 0.153 | -0.131 | 0.282 | 0.226 | 0.221 | 0.067 | 0.297 | 0.336 |
|---|
| rnf5 | | 1 | 164 | 199 | 209 | -0.083 | 0.135 | 0.106 | 0.102 | 0.103 | 0.256 | -0.003 | -0.018 | 0.057 | 0.041 | 0.187 | 0.030 | 0.070 |
|---|
| sprr1a | | 1 | 164 | 199 | 209 | 0.102 | 0.150 | 0.079 | 0.111 | 0.079 | 0.026 | 0.245 | 0.195 | 0.067 | -0.056 | 0.135 | -0.036 | -0.116 |
|---|
| dnm2 | | 6 | 43 | 93 | 81 | 0.089 | 0.127 | 0.114 | -0.049 | 0.065 | 0.251 | 0.291 | 0.177 | -0.039 | -0.048 | -0.099 | -0.044 | 0.262 |
|---|
| acta1 | | 6 | 43 | 44 | 40 | -0.003 | 0.098 | -0.008 | -0.030 | 0.119 | 0.174 | 0.376 | 0.024 | 0.182 | 0.214 | -0.013 | 0.048 | 0.201 |
|---|
| dynll1 | | 5 | 50 | 93 | 82 | -0.012 | 0.108 | 0.088 | 0.087 | 0.098 | 0.124 | 0.134 | 0.128 | 0.113 | 0.093 | 0.158 | 0.074 | 0.360 |
|---|
GO Enrichment output for subnetwork 6048-7-real in each dataset
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 |  | 1.624E-11 | 3.736E-08 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 4.077E-10 | 4.689E-07 |
|---|
| spindle organization | GO:0007051 | | 5.436E-10 | 4.168E-07 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 1.066E-09 | 6.128E-07 |
|---|
| cell killing | GO:0001906 | | 3.224E-09 | 1.483E-06 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 1.914E-08 | 7.339E-06 |
|---|
| microtubule cytoskeleton organization | GO:0000226 | | 1.118E-07 | 3.675E-05 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 1.259E-07 | 3.62E-05 |
|---|
| interphase | GO:0051325 | | 1.414E-07 | 3.613E-05 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 1.715E-06 | 3.945E-04 |
|---|
| keratinization | GO:0031424 | | 1.734E-06 | 3.625E-04 |
|---|
IPC-NIBC-129 file
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 | | 1.539E-12 | 3.759E-09 |
|---|
| spindle organization | GO:0007051 | | 4.127E-11 | 5.041E-08 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 6.445E-11 | 5.249E-08 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 1.518E-10 | 9.269E-08 |
|---|
| cell killing | GO:0001906 | | 4.178E-10 | 2.041E-07 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 3.851E-09 | 1.568E-06 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 1.343E-08 | 4.687E-06 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 2.017E-07 | 6.16E-05 |
|---|
| leukocyte mediated immunity | GO:0002443 | | 3.602E-07 | 9.777E-05 |
|---|
| peptide cross-linking | GO:0018149 | | 4.206E-07 | 1.028E-04 |
|---|
| negative regulation of phosphorylation | GO:0042326 | | 8.763E-07 | 1.946E-04 |
|---|
Ivshina_GPL96-GPL97 file
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 | | 2.985E-12 | 7.182E-09 |
|---|
| spindle organization | GO:0007051 | | 9.425E-11 | 1.134E-07 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 1.25E-10 | 1.002E-07 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 2.942E-10 | 1.77E-07 |
|---|
| cell killing | GO:0001906 | | 8.098E-10 | 3.897E-07 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 7.457E-09 | 2.99E-06 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 2.605E-08 | 8.954E-06 |
|---|
| interphase | GO:0051325 | | 3.047E-08 | 9.165E-06 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 3.653E-07 | 9.766E-05 |
|---|
| leukocyte mediated immunity | GO:0002443 | | 6.574E-07 | 1.582E-04 |
|---|
| peptide cross-linking | GO:0018149 | | 6.904E-07 | 1.51E-04 |
|---|
Loi_GPL570 file
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 | | 1.539E-12 | 3.759E-09 |
|---|
| spindle organization | GO:0007051 | | 4.127E-11 | 5.041E-08 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 6.445E-11 | 5.249E-08 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 1.518E-10 | 9.269E-08 |
|---|
| cell killing | GO:0001906 | | 4.178E-10 | 2.041E-07 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 3.851E-09 | 1.568E-06 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 1.343E-08 | 4.687E-06 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 2.017E-07 | 6.16E-05 |
|---|
| leukocyte mediated immunity | GO:0002443 | | 3.602E-07 | 9.777E-05 |
|---|
| peptide cross-linking | GO:0018149 | | 4.206E-07 | 1.028E-04 |
|---|
| negative regulation of phosphorylation | GO:0042326 | | 8.763E-07 | 1.946E-04 |
|---|
Loi_GPL96-GPL97 file
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 | | 2.985E-12 | 7.182E-09 |
|---|
| spindle organization | GO:0007051 | | 9.425E-11 | 1.134E-07 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 1.25E-10 | 1.002E-07 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 2.942E-10 | 1.77E-07 |
|---|
| cell killing | GO:0001906 | | 8.098E-10 | 3.897E-07 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 7.457E-09 | 2.99E-06 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 2.605E-08 | 8.954E-06 |
|---|
| interphase | GO:0051325 | | 3.047E-08 | 9.165E-06 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 3.653E-07 | 9.766E-05 |
|---|
| leukocyte mediated immunity | GO:0002443 | | 6.574E-07 | 1.582E-04 |
|---|
| peptide cross-linking | GO:0018149 | | 6.904E-07 | 1.51E-04 |
|---|
Parker_GPL1390 file
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 8.614E-10 | 3.076E-06 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 5.864E-09 | 1.047E-05 |
|---|
| cyclin-dependent protein kinase holoenzyme complex | GO:0000307 | | 2.997E-08 | 3.568E-05 |
|---|
| cyclin-dependent protein kinase regulator activity | GO:0016538 | | 8.818E-08 | 7.872E-05 |
|---|
| negative regulation of phosphorylation | GO:0042326 | | 8.184E-07 | 5.845E-04 |
|---|
| negative regulation of phosphorus metabolic process | GO:0010563 | | 9.407E-07 | 5.599E-04 |
|---|
| spindle organization | GO:0007051 | | 1.935E-06 | 9.871E-04 |
|---|
| cytoplasmic dynein complex | GO:0005868 | | 7.176E-06 | 3.203E-03 |
|---|
| skeletal myofibril assembly | GO:0014866 | | 7.176E-06 | 2.847E-03 |
|---|
| spindle assembly | GO:0051225 | | 7.176E-06 | 2.562E-03 |
|---|
| G1/S transition of mitotic cell cycle | GO:0000082 | | 7.969E-06 | 2.587E-03 |
|---|
Parker_GPL887 file
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 1.081E-09 | 3.943E-06 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 1.097E-08 | 2.001E-05 |
|---|
| interphase | GO:0051325 | | 1.242E-08 | 1.51E-05 |
|---|
| cyclin-dependent protein kinase holoenzyme complex | GO:0000307 | | 4.168E-08 | 3.801E-05 |
|---|
| cyclin-dependent protein kinase regulator activity | GO:0016538 | | 2.699E-07 | 1.969E-04 |
|---|
| spindle organization | GO:0007051 | | 2.152E-06 | 1.308E-03 |
|---|
| negative regulation of phosphorylation | GO:0042326 | | 2.409E-06 | 1.255E-03 |
|---|
| negative regulation of phosphorus metabolic process | GO:0010563 | | 3.299E-06 | 1.504E-03 |
|---|
| muscle thin filament assembly | GO:0030240 | | 8.717E-06 | 3.533E-03 |
|---|
| RNA polymerase II carboxy-terminal domain kinase activity | GO:0008353 | | 8.717E-06 | 3.18E-03 |
|---|
| G1/S transition of mitotic cell cycle | GO:0000082 | | 8.993E-06 | 2.982E-03 |
|---|
Pawitan_GPL96-GPL97 file
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 | | 2.985E-12 | 7.182E-09 |
|---|
| spindle organization | GO:0007051 | | 9.425E-11 | 1.134E-07 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 1.25E-10 | 1.002E-07 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 2.942E-10 | 1.77E-07 |
|---|
| cell killing | GO:0001906 | | 8.098E-10 | 3.897E-07 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 7.457E-09 | 2.99E-06 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 2.605E-08 | 8.954E-06 |
|---|
| interphase | GO:0051325 | | 3.047E-08 | 9.165E-06 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 3.653E-07 | 9.766E-05 |
|---|
| leukocyte mediated immunity | GO:0002443 | | 6.574E-07 | 1.582E-04 |
|---|
| peptide cross-linking | GO:0018149 | | 6.904E-07 | 1.51E-04 |
|---|
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 | | 1.624E-11 | 3.736E-08 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 4.077E-10 | 4.689E-07 |
|---|
| spindle organization | GO:0007051 | | 5.436E-10 | 4.168E-07 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 1.066E-09 | 6.128E-07 |
|---|
| cell killing | GO:0001906 | | 3.224E-09 | 1.483E-06 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 1.914E-08 | 7.339E-06 |
|---|
| microtubule cytoskeleton organization | GO:0000226 | | 1.118E-07 | 3.675E-05 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 1.259E-07 | 3.62E-05 |
|---|
| interphase | GO:0051325 | | 1.414E-07 | 3.613E-05 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 1.715E-06 | 3.945E-04 |
|---|
| keratinization | GO:0031424 | | 1.734E-06 | 3.625E-04 |
|---|
Sotiriou file
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 | | 1.624E-11 | 3.736E-08 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 4.077E-10 | 4.689E-07 |
|---|
| spindle organization | GO:0007051 | | 5.436E-10 | 4.168E-07 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 1.066E-09 | 6.128E-07 |
|---|
| cell killing | GO:0001906 | | 3.224E-09 | 1.483E-06 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 1.914E-08 | 7.339E-06 |
|---|
| microtubule cytoskeleton organization | GO:0000226 | | 1.118E-07 | 3.675E-05 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 1.259E-07 | 3.62E-05 |
|---|
| interphase | GO:0051325 | | 1.414E-07 | 3.613E-05 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 1.715E-06 | 3.945E-04 |
|---|
| keratinization | GO:0031424 | | 1.734E-06 | 3.625E-04 |
|---|
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 | | 1.624E-11 | 3.736E-08 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 4.077E-10 | 4.689E-07 |
|---|
| spindle organization | GO:0007051 | | 5.436E-10 | 4.168E-07 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 1.066E-09 | 6.128E-07 |
|---|
| cell killing | GO:0001906 | | 3.224E-09 | 1.483E-06 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 1.914E-08 | 7.339E-06 |
|---|
| microtubule cytoskeleton organization | GO:0000226 | | 1.118E-07 | 3.675E-05 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 1.259E-07 | 3.62E-05 |
|---|
| interphase | GO:0051325 | | 1.414E-07 | 3.613E-05 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 1.715E-06 | 3.945E-04 |
|---|
| keratinization | GO:0031424 | | 1.734E-06 | 3.625E-04 |
|---|
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 | | 1.624E-11 | 3.736E-08 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 4.077E-10 | 4.689E-07 |
|---|
| spindle organization | GO:0007051 | | 5.436E-10 | 4.168E-07 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 1.066E-09 | 6.128E-07 |
|---|
| cell killing | GO:0001906 | | 3.224E-09 | 1.483E-06 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 1.914E-08 | 7.339E-06 |
|---|
| microtubule cytoskeleton organization | GO:0000226 | | 1.118E-07 | 3.675E-05 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 1.259E-07 | 3.62E-05 |
|---|
| interphase | GO:0051325 | | 1.414E-07 | 3.613E-05 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 1.715E-06 | 3.945E-04 |
|---|
| keratinization | GO:0031424 | | 1.734E-06 | 3.625E-04 |
|---|
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| spindle assembly | GO:0051225 | | 3.435E-11 | 8.152E-08 |
|---|
| natural killer cell mediated immunity | GO:0002228 | | 2.878E-10 | 3.415E-07 |
|---|
| spindle organization | GO:0007051 | | 5.877E-10 | 4.649E-07 |
|---|
| leukocyte mediated cytotoxicity | GO:0001909 | | 7.524E-10 | 4.464E-07 |
|---|
| cell killing | GO:0001906 | | 2.276E-09 | 1.08E-06 |
|---|
| G2/M transition of mitotic cell cycle | GO:0000086 | | 1.353E-08 | 5.349E-06 |
|---|
| interphase of mitotic cell cycle | GO:0051329 | | 8.725E-08 | 2.958E-05 |
|---|
| interphase | GO:0051325 | | 9.784E-08 | 2.902E-05 |
|---|
| microtubule cytoskeleton organization | GO:0000226 | | 1.035E-07 | 2.729E-05 |
|---|
| lymphocyte mediated immunity | GO:0002449 | | 1.565E-06 | 3.714E-04 |
|---|
| keratinization | GO:0031424 | | 1.598E-06 | 3.446E-04 |
|---|
